These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1806234)

  • 1. Intracoronary adenosine and papaverine do not increase myocardial systolic thickening.
    Kiesz RS; Gehman JD; Gascho JA
    Cardiovasc Res; 1991 Dec; 25(12):1042-50. PubMed ID: 1806234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
    Christensen CW; Rosen LB; Gal RA; Haseeb M; Lassar TA; Port SC
    Circulation; 1991 Jan; 83(1):294-303. PubMed ID: 1984887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary papaverine but not adenosine reduces regional ventricular function.
    Martin SE; Schmarkey LS; Oh DJ; Patterson RE
    Cardiovasc Res; 1993 Nov; 27(11):2028-36. PubMed ID: 8287414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adenosine on human coronary arterial circulation.
    Wilson RF; Wyche K; Christensen BV; Zimmer S; Laxson DD
    Circulation; 1990 Nov; 82(5):1595-606. PubMed ID: 2225364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary reperfusion: effects of vasodilators (papaverine and adenosine).
    Parker PE; Bashour FA; Downey HF; Boutros IS
    Am Heart J; 1977 Jan; 93(1):66-72. PubMed ID: 831413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does pharmacologic coronary flow reserve reflect vasodilator responsiveness to increased myocardial demand in humans?
    Rossen JD; Nahser PJ; Oskarsson H; Brown RE; Winniford MD
    Coron Artery Dis; 1996 Jun; 7(6):479-84. PubMed ID: 8889365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
    De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
    Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve.
    Zijlstra F; Juillière Y; Serruys PW; Roelandt JR
    Cathet Cardiovasc Diagn; 1988; 15(2):76-80. PubMed ID: 3180211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of coronary flow reserve using adenosine 5'-triphosphate in dogs].
    Kohno H; Yamada H; Azuma A; Kondo M; Yagi T; Kawata K; Tatsukawa H; Sugihara H; Nakagawa M
    J Cardiol; 1998 Jul; 32(1):1-8. PubMed ID: 9739511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inverse relationship between coronary flow velocity and myocardial oxygen extraction during intracoronary infusion of papaverine].
    Mikuniya A; Higashiyama A; Mikami M; Fujino Y; Sasaki N; Sasaki M; Fukushi T; Narita T; Onodera K; Oike Y
    J Cardiol; 1992; 22(2-3):549-56. PubMed ID: 1339814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence against the adenosine-catecholamine antagonism in the canine heart in situ.
    Schipke J; Heusch G; Thämer V
    Arzneimittelforschung; 1987 Dec; 37(12):1345-7. PubMed ID: 3449061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia-induced depressed systolic thickening is transiently augmented by remote coronary occlusion.
    Gascho JA; Copenhaver GL; Davidson WR
    Cathet Cardiovasc Diagn; 1992 Mar; 25(3):253-9. PubMed ID: 1571984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of supranormal coronary blood flow on energy metabolism and systolic function of porcine left ventricle.
    Schwartz GG; Schaefer S; Trocha SD; Garcia J; Steinman S; Massie BM; Weiner MW
    Cardiovasc Res; 1992 Oct; 26(10):1001-6. PubMed ID: 1486583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine for controlled hypotension: systemic compared with intracoronary infusion in dogs.
    Sidi A; Rush W
    Anesth Analg; 1992 Sep; 75(3):319-28. PubMed ID: 1510251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary hyperemic dose responses of intracoronary sodium nitroprusside.
    Parham WA; Bouhasin A; Ciaramita JP; Khoukaz S; Herrmann SC; Kern MJ
    Circulation; 2004 Mar; 109(10):1236-43. PubMed ID: 14993141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
    van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary transport reserve in normal dogs.
    Laughlin MH
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Aug; 57(2):551-61. PubMed ID: 6088451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of dobutamine on the coronary microcirculation: comparison with adenosine using myocardial contrast echocardiography.
    Bin JP; Le DE; Jayaweera AR; Coggins MP; Wei K; Kaul S
    J Am Soc Echocardiogr; 2003 Aug; 16(8):871-9. PubMed ID: 12878997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries.
    Takeuchi M; Nohtomi Y; Kuroiwa A
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary propofol does not decrease myocardial contractile function in the dog.
    Belo SE; Kolesar R; Mazer CD
    Can J Anaesth; 1994 Jan; 41(1):43-9. PubMed ID: 8111942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.